Machine signal
Active cluster buy — 7 distinct insiders, $7.9M, window ends Aug 14, 2026.
Figures computed from official regulatory filings — .
Analysttarget 5.03 USD (+744%) · consensus 4.5/5 · 3 buy · 1 hold · 0 sell
Ownershipinsiders 12.64% · institutions 16.67% · short 14.0% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Outlook Therapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. Outlook Therapeutics, Inc. was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
76 buys25 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Lundquist Kevin Michael | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Sukhtian Ghiath M.track record | BuyD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | Cluster | SEC |
| KENYON LAWRENCE Atrack record | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |
| Sukhtian Ghiath M.track record | Buy | $2.5M | conv 35Cluster | SEC |
| KENYON LAWRENCE Atrack record | Buy | n/a (No price was disclosed in the filing) | conv 73ClusterFirst in 12mo | SEC |
| Jahr Robert Charles | Buy | n/a (No price was disclosed in the filing) | conv 64ClusterFirst in 12mo | SEC |
| Jahr Robert Charles | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |
| Sukhtian Faisal Ghiathtrack record | Buy | $100K | conv 68ClusterUnusual size | SEC |
| Jahr Robert Charles | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| KENYON LAWRENCE Atrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Haddadin Yezan Munthertrack record | Buy | $24.1K | conv 54Cluster | SEC |
| Sukhtian Ghiath M.track record | Buy | $5M | conv 67ClusterFirst in 12mo | SEC |
| Sukhtian Ghiath M.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Sukhtian Ghiath M.track record | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |
| Sukhtian Ghiath M.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Sukhtian Ghiath M.track record | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |
| Sukhtian Ghiath M.track record | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |
| Sukhtian Ghiath M.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Haddadin Yezan Munthertrack record | Buy | $15K | conv 73ClusterFirst in 12mo | SEC |
| THURMAN RANDY Htrack record | Buy | $2.1K | conv 73ClusterFirst in 12mo | SEC |
| Sukhtian Faisal Ghiathtrack record | Buy | $50K | conv 73ClusterUnusual size+1 | SEC |
| HILZINGER KURT Jtrack record | Buy | $176.5K | conv 89ClusterUnusual size+1 | SEC |
| Haller Julia A | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| HILZINGER KURT Jtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Haddadin Yezan Munthertrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |